Renalytix AI plc Made Big Gain

Mon, Mar 04, 2024 at 07:16 PM

Renalytix AI plc (RNLX:NASDAQ) shot up at $1.47, representing a gain of 41.3%. On Mon, Mar 04, 2024, RNLX:NASDAQ touched a New 2-Week High of $1.47. The stock appeared on our News Catalysts scanner on Thu, Feb 15, 2024 at 09:40 AM in the 'EARNINGS' category. From Tue, Feb 20, 2024, the stock recorded 66.67% Up Days and 40.00% Green Days

The stock spiked on Mon, Feb 12, 2024 at $2.4 with a volume of 52M+.

About Renalytix AI plc (RNLX:NASDAQ)

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally.

Top 10 Gainers:

SRAX, Inc. (SRAX:NASDAQ), 566.67%
Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
BitFuFu Inc. (FUFU:NASDAQ), 105.8%
Ocean Biomedical Inc Com (OCEA:NASDAQ), 104%
Phunware, Inc. (PHUN:NASDAQ), 75.28%
Jaguar Health, Inc. (JAGX:NASDAQ), 61.58%
Satellogic Inc. (SATL:NASDAQ), 46.31%
Energem Corp (ENCP:NASDAQ), 44%
Renalytix AI plc (RNLX:NASDAQ), 41.35%
Envoy Med Inc Cl A (COCH:NASDAQ), 39.2%